MENU
+Compare
RSMDF
Stock ticker: OTC
AS OF
Sep 25 closing price
Price
$26.50
Change
+$1.64 (+6.60%)
Capitalization
39.14B

RSMDF Resmed Inc. Forecast, Technical & Fundamental Analysis

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea... Show more

RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for RSMDF with price predictions
Sep 24, 2025

Momentum Indicator for RSMDF turns positive, indicating new upward trend

RSMDF saw its Momentum Indicator move above the 0 level on August 25, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 35 similar instances where the indicator turned positive. In of the 35 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for RSMDF just turned positive on August 27, 2025. Looking at past instances where RSMDF's MACD turned positive, the stock continued to rise in of 27 cases over the following month. The odds of a continued upward trend are .

RSMDF moved above its 50-day moving average on September 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RSMDF crossed bullishly above the 50-day moving average on September 17, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 14 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 150 cases where RSMDF Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 9 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 37 cases where RSMDF's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.502) is normal, around the industry mean (10.793). P/E Ratio (27.865) is within average values for comparable stocks, (55.895). Projected Growth (PEG Ratio) (1.785) is also within normal values, averaging (1.720). Dividend Yield (0.008) settles around the average of (0.016) among similar stocks. P/S Ratio (7.587) is also within normal values, averaging (13.997).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. RSMDF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. RSMDF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 92, placing this stock better than average.

View a ticker or compare two or three
RSMDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

RSMDF is expected to report earnings to 25 cents per share on October 23

Resmed Inc. RSMDF Stock Earnings Reports
Q3'25
Est.
$0.25
Q2'25
Beat
by $0.01
Q1'25
Est.
$0.24
Q4'24
Beat
by $0.01
Q3'24
Beat
by $0.01
The last earnings report on July 31 showed earnings per share of 25 cents, beating the estimate of 24 cents. With 179.00 shares outstanding, the current market capitalization sits at 39.14B.
A.I.Advisor
published Dividends

RSMDF paid dividends on September 18, 2025

Resmed Inc. RSMDF Stock Dividends
А dividend of $0.06 per share was paid with a record date of September 18, 2025, and an ex-dividend date of August 13, 2025. Read more...
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
N/A
Address
9001 Spectrum Center Boulevard
Phone
+1 858 836-5000
Employees
10140
Web
https://www.resmed.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LHX289.345.34
+1.88%
L3Harris Technologies
GSUN2.82-0.01
-0.35%
Golden Sun Health Technology Group Limited
QTWO73.45-0.30
-0.41%
Q2 Holdings
SCSC43.85-0.69
-1.55%
ScanSource
REKR1.76-0.03
-1.68%
Rekor Systems

RSMDF and Stocks

Correlation & Price change

A.I.dvisor tells us that RSMDF and NAOV have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that RSMDF and NAOV's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
N/A
NAOV - RSMDF
30%
Poorly correlated
-6.17%
PODD - RSMDF
25%
Poorly correlated
-1.00%
ANIK - RSMDF
25%
Poorly correlated
-0.77%
FLGT - RSMDF
25%
Poorly correlated
-0.36%
PACB - RSMDF
24%
Poorly correlated
-2.80%
More

Groups containing RSMDF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RSMDF
1D Price
Change %
RSMDF100%
N/A
Pharmaceuticals
category (388 stocks)
8%
Poorly correlated
-0.89%
Pharmaceuticals: Other
category (103 stocks)
4%
Poorly correlated
-0.99%